Literature DB >> 18427654

Transvenous biventricular pacing for cardiac resynchronization therapy in patients with persistent left superior vena cava and right superior vena cava atresia.

J Alberto Lopez1.   

Abstract

Biventricular pacing for cardiac resynchronization therapy is an effective adjunctive therapy for the treatment of symptomatic moderate and severe congestive heart failure. However, experience with transvenous cardiac resynchronization therapy in patients who have both persistent left superior vena cava and right superior vena cava atresia is extremely limited. We successfully performed cardiac resynchronization therapy in 2 patients who had persistent left superior vena cava, right superior vena cava atresia, and congestive heart failure. Our 2 cases demonstrate the possibility of a total transvenous approach for left ventricular pacing despite the presence of serious cardiac venous anomalies. This approach enables clinicians to avoid the riskier epicardial lead placement, which requires a thoracotomy under general anesthesia.

Entities:  

Keywords:  Cardiac pacing, artificial/methods; cardiac resynchronization therapy; coronary vessel anomalies; heart defects, congenital/therapy; heart failure/therapy; pacemaker, artificial; persistent left superior vena cava; right superior vena cava atresia; vena cava, superior/abnormalities

Mesh:

Year:  2008        PMID: 18427654      PMCID: PMC2322890     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  7 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  The left-sided superior vena cava.

Authors:  M CAMPBELL; D C DEUCHAR
Journal:  Br Heart J       Date:  1954-10

3.  Implantation of a dual chamber pacemaker in a patient with persistent left superior vena cava.

Authors:  L Y Dirix; I E Kersschot; H Fierens; M A Goethals; G Van Daele; G Claessen
Journal:  Pacing Clin Electrophysiol       Date:  1988-03       Impact factor: 1.976

4.  Pathogenesis of persistent left superior vena cava with a coronary sinus connection.

Authors:  E N Nsah; G W Moore; G M Hutchins
Journal:  Pediatr Pathol       Date:  1991 Mar-Apr

Review 5.  Retiming the failing heart: principles and current clinical status of cardiac resynchronization.

Authors:  Christophe Leclercq; David A Kass
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

Review 6.  Persistent left superior vena cava draining into the coronary sinus: report of 10 cases and literature review.

Authors:  Carlos Gonzalez-Juanatey; Ana Testa; Juan Vidan; Ricardo Izquierdo; Alberto Garcia-Castelo; Celedonio Daniel; Victor Armesto
Journal:  Clin Cardiol       Date:  2004-09       Impact factor: 2.882

7.  Transvenous defibrillator implantation in patients with persistent left superior vena cava and right superior vena cava atresia.

Authors:  S Favale; G H Bardy; M V Pitzalis; C D Dicandia; M Traversa; P Rizzon
Journal:  Eur Heart J       Date:  1995-05       Impact factor: 29.983

  7 in total
  3 in total

1.  Perforation of the right ventricle during cardiac resynchronisation therapy upgrade not related to a coexisting persistent left superior vena cava.

Authors:  Rui Providência; Luís V Paiva; Romeu Cação; Paula Mota
Journal:  BMJ Case Rep       Date:  2012-08-24

2.  Persistent Left Superior Vena Cava in Patients Undergoing Cardiac Device Implantation: Clinical and Long-Term Data.

Authors:  Dubravko Petrac; Vjekoslav Radeljic; Nikola Pavlovic; Sime Manola; Diana Delic-Brkljacic
Journal:  Cardiol Res       Date:  2013-05-09

3.  Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation.

Authors:  Mauro Biffi; Matteo Bertini; Matteo Ziacchi; Cristian Martignani; Cinzia Valzania; Igor Diemberger; Angelo Branzi; Giuseppe Boriani
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.